AstraZeneca announced that the European Patent Office (EPO) Technical Board of Appeal has made a final ruling that the European Combination patent for Symbicort (formoterol and budesonide) (EPB0613371 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback